Log in to save to my catalogue

Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerati...

Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_feac46e1e16e4db6837ec810e6c4879f

Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis

About this item

Full title

Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-11, Vol.13 (1), p.20262-20262, Article 20262

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Not all patients with ulcerative colitis (UC) respond initially to treatment with biologic agents, and predicting their efficacy prior to treatment is difficult. Vedolizumab, a humanized monoclonal antibody against alpha 4 beta 7 (α4β7) integrin, suppresses immune cell migration by blocking the interaction between α4β7 integrin and mucosal addressi...

Alternative Titles

Full title

Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_feac46e1e16e4db6837ec810e6c4879f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_feac46e1e16e4db6837ec810e6c4879f

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-47618-3

How to access this item